Our work has shown that two heterozygous rare missense mutations in LMNA are associated with severe metabolic alterations, such as hypertriglyceridemia and insulin resistance, and are associated with premature senescence at the cellular level. The gene discussed is LMNA; the disease is Insulin resistance.